- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03396094
Pre- and Apnoeic Oxygenation for RSI in ED (Pre-AeRATE)
Pre- and Apnoeic High Flow Oxygenation for RApid Sequence Intubation in The Emergency Department (Pre-AeRATE): a Multicentre Randomised Controlled Trial
Critically ill patients may need support for breathing by means of intubation, which is placement of a breathing tube into the windpipe. Rapid sequence intubation (RSI) is a method commonly used and is performed by administering medications to induce coma and muscle paralysis, followed by intubation to allow the ventilator to provide oxygen into the lungs. This procedure may be filled with potential complications.
During RSI, the patient stops spontaneous breathing after medically induced muscle paralysis occurs. Adequate oxygenation before and during paralysis is crucial to increase the reserves and prolong the time that oxygen levels in the blood remain above 90%, called the safe apnoea period. If the oxygen reserves are insufficient, the blood oxygen level will drop and can lead to permanent brain damage or even death.
This study aims to explore if delivering high-flow humidified oxygen at 60L/min via the nostrils would be superior to current methods of mask ventilation at 15L/min and nasal cannula at 15L/min, before and during paralysis respectively. If successful, this new method would allow for a longer safe apnoeic period and increase the chances for doctors to perform intubation successfully without the blood oxygen dropping below 90%.
Study Overview
Status
Conditions
Detailed Description
Maintaining adequate oxygenation during rapid sequence intubation (RSI) is imperative to prevent peri-intubation adverse events that can lead to increased duration of hospital and intensive care unit stay, or prolonged vegetative state requiring long-term institutionalisation.
Preliminary data from our emergency department (ED) airway registry revealed that 15% of patients experienced desaturation during intubation despite employing current best practices during RSI. In this multicentre randomised controlled trial in the ED, we aim to test the hypothesis that use of humidified high flow oxygenation via nasal cannula (HFNC) at 60L/min maintains higher oxygen saturation compared with current usual care using non-rebreather mask for preoxygenation and provides superior apnoeic oxygenation compared to the typical practice of 15L/min via standard nasal cannula.
The main goal of the study would be to improve on the lowest oxygen saturation during intubation, and thereby increase the safe apnoeic time during RSI. We plan to enrol adult patients who require rapid sequence intubation due to medical, surgical or traumatic conditions in the EDs of National University Hospital and Ng Teng Fong General Hospital.
Eligible patients will undergo block randomisation at equal ratio into 2 possible treatment combinations of pre-oxygenation and apnoeic oxygenation. The primary endpoint will be the lowest oxygen saturation achieved from time of administration of paralytic agent until quantitative end-tidal carbon dioxide is detected for the first intubation attempt.
Higher failure rates for intubation in unfasted patients in the ED compared to fasted patients in elective settings increase the risk of aspiration if re-oxygenation is required with bag-valve-mask ventilation. Prolongation of safe apnoea time through maintenance of oxygen saturation above 90% using HFNC oxygenation during RSI could potentially change current clinical practice, improve standard of care and translate to better outcomes for patients.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Singapore, Singapore
- National University Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Adult patients aged 21 years and above, who require RSI due to medical, surgical and traumatic conditions, in the Emergency Departments of NUH and Ng Teng Fong General Hospital (NTFGH)
Exclusion Criteria:
- Patients with "do-not-resuscitate" orders
- Crash, awake or delayed sequence intubations
- Patients requiring non-invasive positive pressure ventilation
- Cardiac arrest
- Clinical suspicion or confirmed diagnosis of base of skull fractures or severe facial trauma that precludes nasal cannula placement
- Vulnerable patient populations (e.g. pregnant women, prisoners)
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Intervention
High-flow nasal cannula oxygenation at 60L/min for pre-oxygenation and apnoeic oxygenation
|
Delivery of 60L/min of supplemental oxygen for pre-oxygenation and apnoeic oxygenation during rapid sequence intubation using the AIRVO™ 2 Humidifier with Integrated Flow Generator (Fisher & Paykel Healthcare, Auckland, New Zealand)
Other Names:
|
Active Comparator: Control
Pre-oxygenation using non-rebreather mask and apnoeic oxygenation via nasal cannulae at 15L/min
|
Pre-oxygenation using non-rebreather mask and apnoeic oxygenation via nasal cannulae at 15L/min
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Lowest SpO2 achieved during first intubation attempt
Time Frame: From time of administration of paralytic agent until quantitative ETCO2 is detected post-intubation up to 45 minutes
|
Lowest SpO2 achieved during first intubation attempt which is defined as first attempt to insert endotracheal tube into oropharynx
|
From time of administration of paralytic agent until quantitative ETCO2 is detected post-intubation up to 45 minutes
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Number of attempts at intubation
Time Frame: Number of attempts required until successful intubation up to 45 minutes or termination of procedure, whichever is earlier
|
Number of attempts until successful intubation as indicated by detection of quantitative ETCO2
|
Number of attempts required until successful intubation up to 45 minutes or termination of procedure, whichever is earlier
|
Safe apnoea time during intubation
Time Frame: From start of paralysis to time when SpO2 drops to less than 90% up to 45 minutes
|
Duration of apnoea where SpO2 remains ≥ 90%
|
From start of paralysis to time when SpO2 drops to less than 90% up to 45 minutes
|
Incidence of SpO2 < 90%
Time Frame: From start of paralysis to successful intubation up to 45 minutes
|
Incidence of SpO2 < 90% during apnoea
|
From start of paralysis to successful intubation up to 45 minutes
|
Peri-intubation adverse events
Time Frame: From induction to 15 minutes after intubation
|
Peri-intubation adverse events defined as hypotension, hypertension, tachycardia, bradycardia, regurgitation, aspiration, cardiac arrhythmia, cardiac arrest during RSI, oropharynx or dental trauma
|
From induction to 15 minutes after intubation
|
Length of time to successful intubation
Time Frame: From induction until successful intubation as confirmed by detection of quantitative ETCO2 up to 45 minutes
|
Time taken from induction to successful intubation attempt
|
From induction until successful intubation as confirmed by detection of quantitative ETCO2 up to 45 minutes
|
Collaborators and Investigators
Investigators
- Principal Investigator: Mui Teng Chua, MBBS, MPH, National University Hospital, Singapore
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- CNIG17may007
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Intubation
-
Spanish Network for Research in Infectious DiseasesCompletedIntubation | Intubation Complication | Intubation; Difficult or FailedSpain
-
University Hospital, Clermont-FerrandSociété Française d'Anesthésie-Réanimation (SFAR)Not yet recruitingEndotracheal Intubation | Intubation Complication | Intubation; Difficult or Failed
-
Children's Hospital of PhiladelphiaAgency for Healthcare Research and Quality (AHRQ)RecruitingIntubation Complication | Intubation; Difficult | Failed or Difficult Intubation, SequelaUnited States, Canada, Japan, Italy, New Zealand, Singapore, Australia, Austria, Germany, India, United Kingdom
-
Emory UniversityTerminatedAirway Morbidity | Intubation Complication | Anesthesia Intubation Complication | Tracheal Intubation Morbidity | Failed or Difficult Intubation, SequelaUnited States
-
Catharina Ziekenhuis EindhovenCompletedAnesthesia Intubation Complication | Intubation; Difficult | Failed or Difficult Intubation | Failed or Difficult Intubation, Initial EncounterNetherlands
-
Children's Hospital of PhiladelphiaEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsCompletedIntubation Complication | Intubation;Difficult | Failed or Difficult Intubation, SequelaUnited States, Canada, Singapore
-
Kaohsiung Medical University Chung-Ho Memorial...CompletedIntubation, Nasotracheal IntubationTaiwan
-
University Hospital HeidelbergRecruitingIntubation | Intubation ComplicationGermany
-
Kaohsiung Medical University Chung-Ho Memorial...CompletedIntubation Complication | Intubation, DifficultTaiwan
-
Huazhong University of Science and TechnologyCompletedIntubation Complication | Intubation; DifficultChina
Clinical Trials on High-flow nasal cannulae (HFNC) oxygenation
-
St. Olavs HospitalNorwegian University of Science and TechnologyCompleted
-
Lahore General HospitalUnknownSARS-CoV Infection | SARS (Severe Acute Respiratory Syndrome)Pakistan
-
University of Split, School of MedicineGeneral Hospital DubrovnikUnknownObesity | Hypoxia | Respiratory Insufficiency | Airway Management | Colonoscopy | Noninvasive Ventilation | Deep Sedation
-
Anita VukovicClinical Hospital Centre Zagreb; General Hospital DubrovnikUnknownHypoxia | Respiratory Insufficiency | Airway Management | Colonoscopy | Noninvasive Ventilation | Deep Sedation
-
Nova Scotia Health AuthorityDalhousie UniversityCompleted
-
Chang Gung UniversityCompletedChronic Obstructive Pulmonary DiseaseTaiwan
-
National Taiwan University HospitalCompleted
-
Hôpital de VerdunNot yet recruitingHypercapnic Respiratory Failure | Acute Copd ExacerbationCanada
-
Pontificia Universidad Catolica de ChileCompleted
-
Peking Union Medical College HospitalCompletedElectrical Impedance Tomography | High-flow Nasal CannulaChina